Dechra Pharmaceuticals PLC (OTCMKTS:DCHPF – Get Free Report) shares were down 0.2% on Monday . The stock traded as low as $46.90 and last traded at $46.90. Approximately 700 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 1,687 shares. The stock had previously closed at $47.00.
Dechra Pharmaceuticals Trading Down 0.2 %
The business has a 50-day simple moving average of $46.90 and a 200-day simple moving average of $46.90.
About Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, internal medicine, and nutrition products supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases.
See Also
- Five stocks we like better than Dechra Pharmaceuticals
- How to Calculate Stock Profit
- Intel: Is Now the Time to Be Brave?Â
- Manufacturing Stocks Investing
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Use the MarketBeat Excel Dividend Calculator
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Dechra Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dechra Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20210910161243&h=45&w=95&zc=2){kind=logo}
